Small Molecular Weight Drugs in Allergic Disease
Friday, March 3, 2017: 12:45 PM-2:00 PM
Georgia World Congress Center, Building B, Level 4, Rooms B405-B406
1.25 CME/CE
Christine M. Seroogy , MD FAAAAI

Learning Objectives:
  1. Describe Jakinibs, GATA Dnazyme and CRTH2 antagonists and their potential role in allergic disease treatment
  2. Discuss the mechanisms of novel small molecular weight drugs in allergic disease treatment
  3. Identify novel small molecular weight drugs that are being developed for allergic disease
12:45 PM
John O'Shea Jr., MD
1:00 PM
Question & Answer
1:10 PM
GATA Dnazyme
Harald Renz, MD FAAAAI
1:25 PM
Question & Answer
1:35 PM
William Busse, MD FAAAAI
1:50 PM
Question & Answer
See more of: Session